Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0089
-0.0003 (-3.26%)
Aug 1, 2025, 1:50 PM EDT

Bally's Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
-2.94-3.56-3.96-5.38-5.34-4.67
Upgrade
Depreciation & Amortization
0.090.090.090.0900.01
Upgrade
Other Amortization
0.030.140.230.760.01-
Upgrade
Asset Writedown & Restructuring Costs
---00.020.03
Upgrade
Stock-Based Compensation
0.640.940.230.222.894.3
Upgrade
Other Operating Activities
0.540.541.42-0.270.03
Upgrade
Change in Accounts Payable
0.450.591.552.710.590.11
Upgrade
Change in Other Net Operating Assets
0.260.24-0.050.1-0.04-
Upgrade
Operating Cash Flow
-0.95-1.02-0.49-1.5-1.6-0.19
Upgrade
Capital Expenditures
-----0.01-
Upgrade
Sale (Purchase) of Intangibles
0.02--0.01-0.08-0.01-0.03
Upgrade
Investing Cash Flow
0.02--0.01-0.08-0.02-0.03
Upgrade
Short-Term Debt Issued
--0.041.070.180.43
Upgrade
Total Debt Issued
--0.041.070.180.43
Upgrade
Short-Term Debt Repaid
-----0.05-0.05
Upgrade
Total Debt Repaid
-----0.05-0.05
Upgrade
Net Debt Issued (Repaid)
--0.041.070.130.39
Upgrade
Issuance of Common Stock
0.280.120.110.182.1-
Upgrade
Other Financing Activities
0-0.03-0.08-0.4-0.09-
Upgrade
Financing Cash Flow
1.030.990.50.962.140.39
Upgrade
Net Cash Flow
0.1-0.04-0-0.610.510.16
Upgrade
Free Cash Flow
-0.95-1.02-0.49-1.5-1.61-0.19
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
Upgrade
Cash Interest Paid
0.150.160.120.120.01-
Upgrade
Levered Free Cash Flow
--0.1-2.060.542.15-
Upgrade
Unlevered Free Cash Flow
-0.46-1.430.362.26-
Upgrade
Change in Net Working Capital
--0.950.54-2.83-2.51-
Upgrade
Updated Nov 30, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.